VYGR
Voyager Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$3.51
+3.85%Margins
Gross margin
-104.2%
EBITDA margin
-298.5%
EBIT margin
-340.1%
Net margin
-312.6%
FCF margin
-352.4%
-69.8%
Return on equity
-54.5%
Return on assets
-62.7%
Return on invested capital
0.17x
Asset turnover
-$120.6M
Cash from operations
$1.89
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026